CIK 0001395937
- Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320162505
- Phone
- +1 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-17 | Egros Fabrice Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-05-17 | Egros Fabrice Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2017-05-17 | Chen Henry Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2017-05-17 | Chen Henry Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2017-03-29 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-03-20 | ROYSTON IVOR Director | Returned to the company | −125,000 | $13.75 | $1.7M | 625,545 |
| 2017-02-13 | Shea Richard P Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2017-02-06 | Ordentlich Peter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-02-06 | Morrison Briggs Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2017-02-06 | Meyers Michael L. SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +66,100 | 66,100 | ||
| 2017-02-06 | Metzger Michael A President and COO | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2017-01-04 | Legault Pierre Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-10-31 | Chen Henry Director | Grant or award · Stock Options (Right to buy) | +8,000 | 8,000 | ||
| 2016-10-31 | Sledge George W. Jr. Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-10-31 | Shea Richard P Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-10-31 | ROYSTON IVOR Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-10-31 | Podlesak Dennis Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-10-31 | EVNIN LUKE Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-10-31 | Egros Fabrice Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2016-10-31 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 |
Page 26 of 28 · 550 trades